José Luis López-Campos Bodineau-rekin lankidetzan egindako argitalpenak (20)

2024

  1. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

  2. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2021

  1. COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort

    Respiratory research, Vol. 22, Núm. 1, pp. 36

  2. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

2020

  1. A delphi consensus document on the use of single-inhaler fixed-dose triple therapies in copd patients

    International Journal of COPD, Vol. 15, pp. 1801-1811

  2. A proposed approach to chronic airway disease (CAD) using therapeutic goals and treatable traits: A look to the future

    International Journal of COPD, Vol. 15, pp. 2091-2100

  3. Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10

  4. Sex differences between women and men with COPD: A new analysis of the 3CIA study

    Respiratory Medicine, Vol. 171

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

2017

  1. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD

    The European respiratory journal, Vol. 50, Núm. 5

  2. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

    Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24

2016

  1. Defining the asthma-COPD overlap syndrome in a COPD Cohort

    Chest, Vol. 149, Núm. 1, pp. 45-52

  2. Distribution and outcomes of a phenotype-based approach to guide COPD management: Results from the CHAIN cohort

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Differential effect of modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD

    Chest, Vol. 148, Núm. 1, pp. 159-168

  2. What pulmonologists think about the asthma–COPD overlap syndrome

    International Journal of COPD, Vol. 10, pp. 1321-1330

2014

  1. Clinical application of the COPD assessment test: Longitudinal data from the COPD history assessment in Spain (CHAIN) Cohort

    Chest, Vol. 146, Núm. 1, pp. 111-122

  2. Erratum: New GOLD classification: Longitudinal data on group assignment [Respir Res. 15, (2014) 3, 10.1186/1465-9921-15-3]

    Respiratory Research

  3. New GOLD classification: Longitudinal data on group assignment

    Respiratory Research, Vol. 15, Núm. 1

2012

  1. Chronic obstructive pulmonary disease History Assessment in Spain: Una valoración multidimensional de la enfermedad pulmonar obstructiva crónica. Método y organización del trabajo

    Archivos de Bronconeumologia, Vol. 48, Núm. 12, pp. 453-459